ARROWHEAD PHARMACEUTICALS, INC. Contractual Obligation
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Contractual Obligation of $2.33 million as of 2018-09-30, per its 10-K filed 2018-12-11.
Discontinued › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity
us-gaap:ContractualObligation · last filed 2018-12-11
- 2018-09-30: Contractual Obligation $2.33M.
- 2018-06-30: Contractual Obligation $2.38M.
- 2018-03-31: Contractual Obligation $2.43M.
- 2017-12-31: Contractual Obligation $2.48M.
| Period end | Contractual Obligation |
|---|---|
| 2018-09-30 | $2.33M 10-K · filed 2018-12-11 |
| 2018-06-30 | $2.38M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $2.43M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $2.48M 10-Q · filed 2018-02-09 |
| 2017-09-30 | $2.53M 10-K · filed 2017-12-12 |
| 2017-06-30 | $2.58M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $2.63M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $2.68M 10-Q · filed 2017-02-06 |
| 2016-09-30 | $2.73M 10-K · filed 2016-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |